Zespó Przychodni Specjalistycznych PRIMA
About Zespó Przychodni Specjalistycznych PRIMA
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
4
Celgene
3
Ferring Pharmaceuticals
2
Clinical Trials at Zespó Przychodni Specjalistycznych PRIMA
During the past decade, Zespó Przychodni Specjalistycznych PRIMA conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on
average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies
2014-09-15
2025-08-16
Active, not recruiting
1,822
A Study of the Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors
2014-08-12
2020-04-06
Completed
359
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
2015-03-20
2021-09-07
Completed
1,035
Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144
2015-06-08
2026-05-21
Active, not recruiting
900
Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC)
2015-10-01
2018-04-03
Completed
228
Mesalamine 2 g Sachet for the Maintenance of Clinical and Endoscopic Remission in Ulcerative Colitis (UC)
2016-02-01
2018-09-19
Completed
276
Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease
2018-03-07
2024-06-28
Recruiting
600
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
2018-06-27
2025-06-24
Recruiting
485
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Zespó Przychodni Specjalistycznych PRIMA
According to Clinical.Site data, the most researched conditions in "Zespó Przychodni Specjalistycznych PRIMA" are
"Crohn Disease" (5 trials), "Ulcerative Colitis" (3 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "Zespó Przychodni Specjalistycznych PRIMA" in a lesser frequency.
Clinical Trials Intervention Types at Zespó Przychodni Specjalistycznych PRIMA
Most popular intervention types in "Zespó Przychodni Specjalistycznych PRIMA" are "Drug" (9 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Etrolizumab" (4 trials), "Ozanimod" (3 trials) and "Mesalamine" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Zespó Przychodni Specjalistycznych PRIMA
The vast majority of trials in "Zespó Przychodni Specjalistycznych PRIMA" are
9 trials for "All" genders.
Clinical Trials Status at Zespó Przychodni Specjalistycznych PRIMA
Currently, there are NaN active trials in "Zespó Przychodni Specjalistycznych PRIMA".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Zespó Przychodni Specjalistycznych PRIMA,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Zespó Przychodni Specjalistycznych PRIMA, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".